J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
PLOS ONE | https://doi.org/10.1371/journal.pone.0193145 February 22, 2018 1 / 13
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
PHA 2018; 8(S1): S24–S28
© 2018 The Union
Review Article
Granich et al. Int J Virol AIDS 2018, 5:043 DOI: 10.23937/2469-567X/1510043 Volume 5 | Issue 1
Временные рекомендации 25 января 2020 г.
Tuberculosis cases, TB deaths
HIV/TB workplace policy and Implementation Strategy
IDS Practice Paper in Brief 16
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015